Valsartan
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Logistics Agency (DLA) has issued a solicitation for an unrestricted and fully competitive national requirements contract for Valsartan tablets in various strengths (40mg, 80mg, 160mg, 320mg) and bottle counts (30 or 90). This contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Proposals are due July 9, 2021, at 3:00 PM EST.
Scope of Work
This opportunity is for the procurement of Valsartan 40MG tablets in 30-count bottles, and 80MG, 160MG, and 320MG tablets in 90-count bottles. The contract will establish a national supply source to provide these items through the DLA and VA prime vendor programs. Annual usage estimates will be provided in the Schedule of Supplies.
Key Requirements
Offerors must provide Valsartan tablets registered with RXNorm, First Data Bank, and Medispan prior to contract performance. Unit-of-use packaging must include child-proof closures and meet specific bottle and label dimensions. Bar code labeling at the unit-of-use package level, conforming to GS1-128 or HIBCC standards, is required. Offerors must possess FDA approval (NDA, ANDA, or Biologic License) for the offered drugs, and manufacturing facilities must comply with FDA current Good Manufacturing Practices (cGMP).
Contract Details
- Type: Firm-fixed-price, requirements type contract (FAR 52.216-21).
- Period of Performance: One base year with four one-year options, not to exceed five years.
- Set-Aside: Unrestricted and fully competitive.
- NAICS Code: 325412 (Pharmaceutical and Medicine Manufacturing).
- Size Standard: 1250 Employees.
- Contract Price Effective Date: No more than 60 days after award.
- Contract Performance Date: 45 days after award (or sooner by mutual agreement).
Submission & Evaluation
Offers must be submitted electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS). Evaluation will be based on Lowest Price Technically Acceptable (LPTA) criteria. Proposals must include a Non-Price Proposal (Volume 1) and a Price Proposal (Volume 2). A reverse auction may be utilized for price negotiations.
Important Notes
Offerors must coordinate business-to-business agreements with DLA and VA Prime Vendor (PPV) contractors. Payments will be made by PPV contractors, not directly by the Government. A cost recovery fee of 0.5% is embedded in contract prices. Interested parties should set up automated notifications for solicitation changes.
Key Dates & Contacts
- Proposal Due Date: July 9, 2021, 3:00 PM EST (extended by Amendment 0003).
- Published Date: December 27, 2022 (Presolicitation notice), Solicitation posted June 2, 2021.
- Primary Contact: Christopher Newman (christopher.newman@dla.mil, 215-737-2905).